Literature DB >> 8230489

Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge.

C Sabella1, P W Lowry, G M Abbruzzi, C M Koropchak, P R Kinchington, M Sadegh-Zadeh, J Hay, W T Ruyechan, A M Arvin.   

Abstract

The IE62 protein, the primary regulatory protein of varicella-zoster virus (VZV) and the major component of the virion tegument, was an effective immunogen in the guinea pig model of VZV infection, whereas the ORF 29 gene product, a nonstructural DNA replication protein, did not elicit protection. All animals immunized with the ORF 29 protein had cell-associated viremia compared with 2 of 11 guinea pigs given the IE62 protein (P = 0.005). VZV was detected in ganglia from 38% of the animals given the ORF 29 protein and 44% of the control animals compared with 9% of the animals immunized with the IE62 protein (P = 0.04). In contrast to the IE62 protein, immunization with the ORF 29 protein did not prime the animals for an enhanced T-cell response upon challenge with infectious virus. The VZV IE62 protein has potential value as a vaccine component.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230489      PMCID: PMC238239     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Humoral and cellular immunity to varicella-zoster virus glycoprotein gpI and to a non-glycosylated protein, p170, in the strain 2 guinea-pig.

Authors:  A M Arvin; S M Solem; C M Koropchak; E Kinney-Thomas; S G Paryani
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

2.  Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0.

Authors:  S Martin; X X Zhu; S J Silverstein; R J Courtney; F Yao; F J Jenkins; B T Rouse
Journal:  J Gen Virol       Date:  1990-10       Impact factor: 3.891

3.  Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization.

Authors:  C M Koropchak; S M Solem; P S Diaz; A M Arvin
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses.

Authors:  K D Croen; J M Ostrove; L J Dragovic; S E Straus
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Mapping of two varicella-zoster virus-encoded genes that activate the expression of viral early and late genes.

Authors:  G Inchauspe; S Nagpal; J M Ostrove
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

6.  A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain.

Authors:  L P Perera; J D Mosca; W T Ruyechan; G S Hayward; S E Straus; J Hay
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  The varicella-zoster virus immediate early protein, IE62, can positively regulate its cognate promoter.

Authors:  L P Perera; J D Mosca; M Sadeghi-Zadeh; W T Ruyechan; J Hay
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

8.  Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.

Authors:  P W Lowry; S Solem; B N Watson; C M Koropchak; H M Thackray; P R Kinchington; W T Ruyechan; P Ling; J Hay; A M Arvin
Journal:  J Gen Virol       Date:  1992-04       Impact factor: 3.891

9.  Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction.

Authors:  P W Lowry; C Sabella; C M Koropchak; B N Watson; H M Thackray; G M Abbruzzi; A M Arvin
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

10.  Latent herpesvirus infections of neurons in guinea pigs and humans.

Authors:  R B Tenser; R W Hyman
Journal:  Yale J Biol Med       Date:  1987 Mar-Apr
View more
  6 in total

1.  Translation of varicella-zoster virus genes during human ganglionic latency.

Authors:  Esther Grinfeld; Peter G E Kennedy
Journal:  Virus Genes       Date:  2004-12       Impact factor: 2.332

2.  Varicella zoster virus (VZV) infects and establishes latency in enteric neurons.

Authors:  Jason J Chen; Anne A Gershon; Zhishan Li; Robert A Cowles; Michael D Gershon
Journal:  J Neurovirol       Date:  2011-12-22       Impact factor: 3.739

Review 3.  Modeling Varicella Zoster Virus Persistence and Reactivation - Closer to Resolving a Perplexing Persistent State.

Authors:  Lillian Laemmle; Ronald S Goldstein; Paul R Kinchington
Journal:  Front Microbiol       Date:  2019-07-24       Impact factor: 5.640

Review 4.  Current In Vivo Models of Varicella-Zoster Virus Neurotropism.

Authors:  Ravi Mahalingam; Anne Gershon; Michael Gershon; Jeffrey I Cohen; Ann Arvin; Leigh Zerboni; Hua Zhu; Wayne Gray; Ilhem Messaoudi; Vicki Traina-Dorge
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

5.  Infected peripheral blood mononuclear cells transmit latent varicella zoster virus infection to the guinea pig enteric nervous system.

Authors:  Lin Gan; Mingli Wang; Jason J Chen; Michael D Gershon; Anne A Gershon
Journal:  J Neurovirol       Date:  2014-06-26       Impact factor: 3.739

6.  Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Authors:  Pieter Meysman; Nicolas De Neuter; Esther Bartholomeus; George Elias; Johan Van den Bergh; Marie-Paule Emonds; Geert W Haasnoot; Steven Heynderickx; Johan Wens; Nele R Michels; Julien Lambert; Eva Lion; Frans H J Claas; Herman Goossens; Evelien Smits; Pierre Van Damme; Viggo Van Tendeloo; Philippe Beutels; Arvid Suls; Geert Mortier; Kris Laukens; Benson Ogunjimi
Journal:  Immunogenetics       Date:  2017-12-01       Impact factor: 3.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.